Key actions by disease
Consultations
Useful resources
Related activities
Online learning
All →Documents
All →Solidarity Partners – Platform adaptive randomized trial for new and repurposed Filovirus treatments...
This protocol was written in accordance with the trial design and drug selection recommendations from the Filovirus therapeutics working group at WHO....
WHO Target Product Profiles for mpox Vaccines
This document describes the preferred and minimally acceptable profiles for human vaccines for all clades of mpox. All vaccines considered for use...
A coordinated research roadmap - Mpox virus: Immediate research next steps to contribute to control the...
A scientific conference was held on August 29-30, 2024. It focused on aligning mpox research with outbreak response goals. This meeting was part of a comprehensive effort...
Mpox Vaccine Tracker: List of vaccine candidates in research & developmentSmallpox vaccines have currently have been repurposed and recommended for...
Publications
All →This large, international, randomized controlled clinical trial is designed to enable an expeditious, agile and concurrent evaluation of the benefits and...
WHO R&D Blueprint COVID-19: Informal consultation on the potential inclusion of Favipiravir in a clinical...
There has been some suggestions for the inclusion of Favipiravir in the Solidarity trial.
Currently, there are no licensed vaccines for the prevention of COVID 19. While efforts continue to develop effective vaccines, it is pertinent to examine...